Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MYC | P01106 | 2/20 | 0.38 |
| ▸ | MAX | P61244 | 2/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.38 |
| ▸ | ITGAV | P06756 | 2/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6970220 | 0.88 | MYC (0.38) | LMNAPOLBMYCMAXGPR119 | |
| SCHEMBL6966272 | 0.87 | MYC (0.42) | MYCMAXITGB3ITGA2BITGAV | |
| SCHEMBL6967503 | 0.86 | MYC (0.39) | LMNAMYCMAXGPR119KDM4E | |
| SCHEMBL6976765 | 0.86 | MYC (0.39) | MYCMAXGPR119KDM4EPKM | |
| SCHEMBL7951214 | 0.85 | TGFBR1 (0.44) | GPR119KDM4EPKMMMP13 | |
| SCHEMBL6964258 | 0.85 | MMP13 (0.50) | LMNAMYCMAXGPR119KDM4E | |
| SCHEMBL6968609 | 0.84 | GPR119 (0.39) | LMNAMYCMAXGPR119KDM4E | |
| SCHEMBL6964185 | 0.84 | GPR119 (0.48) | GPR119MMP13 | |
| SCHEMBL6963385 | 0.84 | STS (0.46) | LMNAMYCMAXGPR119KDM4E | |
| SCHEMBL6968993 | 0.84 | MMP13 (0.50) | GPR119KDM4EPKMMMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098878-B1 | BISPIPERIDINES AS ANTITHROMBOTIC AGENTS | CEPHALON FRANCE (FR) | 2003-12-17 | — | — | EP | disclosed |
| US-6333338-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | LABORATOIRE L. LAFON (FR) | 2001-12-25 | — | — | US | disclosed |